Distinguishing Recurrent Primary Brain Tumor from Radiation Injury: A Preliminary Study Using a Susceptibility-Weighted MR Imaging−Guided Apparent Diffusion Coefficient Analysis Strategy

References

1. 1.↵
   1. Brandsma D,
   2. Stalpers L,
   3. Tall W,
   4. et al

   . Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 2008;9:453–61

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Hein PA,
   2. Eskey CJ,
   3. Dunn JF,
   4. et al

   . Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 2004;25:201–09

   Abstract/FREE Full Text
3. 3.↵
   1. Asao C,
   2. Korogi Y,
   3. Kitajima M,
   4. et al

   . Diffusion-weighted imaging of radiation-induced injury for differentiation from tumor recurrence. AJNR Am J Neuroradiol 2005;26:1455–60

   Abstract/FREE Full Text
4. 4.↵
   1. Sundgren PC,
   2. Fan X,
   3. Weybright P,
   4. et al

   . Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions. Mag Reson Imaging 2006;24:1131–42

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Provenzale JM,
   2. Mukundan S,
   3. Barboriak DP

   . Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006;239:632–49

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Sehgal V,
   2. Delproposto Z,
   3. Haddar D,
   4. et al

   . Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 2006;24:41–51

   CrossRefPubMed
7. 7.↵
   1. Kim HS,
   2. Jahng GH,
   3. Ryu CW,
   4. et al

   . Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol 2009;30:1574–79. Epub 2009 May 20

   Abstract/FREE Full Text
8. 8.↵
   1. Pinker K,
   2. Noebauer-Huhmann IM,
   3. Stavrou I,
   4. et al

   . High resolution contrast-enhanced susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathological findings. AJNR Am J Neuroradiol 2007;28:1280–86

   Abstract/FREE Full Text
9. 9.↵
   1. Pinker K,
   2. Noebauer-Huhmann IM,
   3. Stavrou I,
   4. et al

   . High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors. Neuroradiology 2008;50:9–16

   CrossRefPubMed
10. 10.↵
    1. Mittal S,
    2. Wu Z,
    3. Neelavalli J,
    4. et al

    . Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 2009;30:232–52

    Abstract/FREE Full Text
11. 11.↵
    1. Jenkinson M,
    2. Smith S

    . A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143–56

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Smith SM

    . Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143–55

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Sugahara T,
    2. Korogi Y,
    3. Kochi M,
    4. et al

    . Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9:53–60

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Gupta RK,
    2. Cloughesy TF,
    3. Sinha U,
    4. et al

    . Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 2000;50:215–26

    CrossRefPubMed
15. 15.↵
    1. Guo AC,
    2. Cummings TJ,
    3. Dash RC,
    4. et al

    . Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002;224:177–83

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Kono K,
    2. Inoue Y,
    3. Nakayama K,
    4. et al

    . The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001;22:1081–88

    Abstract/FREE Full Text
17. 17.↵
    1. Sadeghi N,
    2. D'Haene N,
    3. Decaestecker C,
    4. et al

    . Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. AJNR Am J Neuroradiol 2008;29:476–82

    Abstract/FREE Full Text